Condition
Complication of Labor and/or Delivery
Total Trials
2
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Remifentanil
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT02447757CompletedPrimary
Efficacy and Satisfaction With Remifentanil Analgesia in Parturients During the Childbirth
NCT00486902Not ApplicableCompleted
Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?
Showing all 2 trials
Research Network
Common Treatments
- Remifentanil1
Active Sponsors
- Northwestern University1
- Brno University Hospital1
- Hospital Sokolov1
Top Investigators
Northwestern University
Related Conditions
- Ketamine Adverse Reaction1
- Effects Of Anesthesia Spinal And Epidural In Pregnancy1